CSL - Pre Utilidad Fiscal





Pre Utilidad Fiscal Cambio Fecha
Alterity Therapeutics Limited AUD -6.26M 1.52M 2025-12
Arca Biopharma USD -31.82M 2.24M 2026-03
aTyr Pharma USD -153K 25.59M 2026-03
Bio Path USD -976K 3.62M 2025-09
Brainstorm Cell Therapeutics USD -2.11M 797K 2025-09
Cara Therapeutics USD -6.8M 1.9M 2026-03
CSL USD 2.61B 1.21B 2025-12
Curis USD -24.2M 43.56M 2026-03
Immunic USD -19.3M 6.28M 2025-12
Minerva Neurosciences USD 22.51M 30.74M 2024-09
Sangamo BioSciences USD -36.05M 12.94M 2024-06
TherapeuticsMD USD -1.05M 241K 2024-06